Alto Neuroscience, Inc. Other Current Assets
Alto Neuroscience, Inc. (ANRO) had Other Current Assets of $23.00 thousand as of 2025-03-31, per its 10-Q filed 2025-05-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2025-05-14
- 2025-03-31: Other Assets, Current $23.00K.
- 2024-12-31: Other Assets, Current $30.00K.
- 2024-09-30: Other Assets, Current $277.00K.
- 2024-06-30: Other Assets, Current $148.00K.
| Period end | Other Assets, Current | Other Assets, Current as first filed |
|---|---|---|
| 2025-03-31 | $23.00K 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $30.00K 10-Q · filed 2025-05-14 | |
| 2024-09-30 | $277.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $148.00K 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $150.00K 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $112.00K 10-K · filed 2025-03-20 | $104.00K 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 |